3M licenses vaccine adjuvants to VaxInnate
This article was originally published in Scrip
Executive Summary
3M has licensed its small-molecule toll-like receptor (TLR) agonists to VaxInnate for use as vaccine adjuvants. It said that data suggested that they could enhance vaccine potency.